Back
Bristol-Myers Squibb Vs. AbbVie Industry Stock Comparison
Buy
58
BMY
Bristol-Myers Squibb
Last Price:
58.73
Seasonality Move:
1.42%
Sell
40
ABBV
AbbVie
Last Price:
181.14
Seasonality Move:
6.07%
Buy
58
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $58.78. The Score for BMY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $177.06. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $58.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
ABBV Stock Price Chart
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 62.13 | Buy |
| Chaikin Money Flow: | -11877272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.31 - 58.27) | Buy |
| Bollinger Bands (100): | (45.42 - 54.94) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.88 | Sell |
| Relative Strength Index (14 RSI): | 43.25 | Sell |
| Chaikin Money Flow: | -10091734 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (171.12 - 198.68) | Sell |
| Bollinger Bands (100): | (176.92 - 198.56) | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.94 | Buy |
| 20-day SMA: | 56.58 | Buy |
| 50-day SMA: | 53.77 | Buy |
| 200-day SMA: | 48.56 | Buy |
| 8-day EMA: | 58.07 | Buy |
| 20-day EMA: | 56.73 | Buy |
| 50-day EMA: | 54.15 | Buy |
| 200-day EMA: | 50.88 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 170.12 | Buy |
| 20-day SMA: | 183.93 | Sell |
| 50-day SMA: | 189.22 | Sell |
| 200-day SMA: | 178.81 | Sell |
| 8-day EMA: | 173.96 | Buy |
| 20-day EMA: | 179.62 | Sell |
| 50-day EMA: | 185.52 | Sell |
| 200-day EMA: | 178.56 | Sell |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.48 per share, and an increase next year of $6.15 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Bristol-Myers Squibb Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||